In breast cancer, Nectin-4 indirectly activates the Wnt pathway via the PI3K/Akt pathway, and this, in turn, contributes to tumor maintenance by replenishing the pool of cancer stem cells [172], which is often implicated in treatment failure and tumor relapse. This evidence concerns the gene AKT1 and neoplasm.